Separate promising research from proven care.
posted on
By the Regenerative Evidence Guide Team Evaluating an Unproven Stem Cell Claim Before You Travel Evaluating an unproven stem cell claim before you travel means asking the same evidence, safety, and …
Continue Reading about Unproven Stem Cell Claims and Travel: Questions to Ask Before You Go →
posted on
By the Regenerative Evidence Guide Team What "Eligibility Criteria" Means Every public clinical trial record lists eligibility criteria — the requirements researchers use to decide who can join a …
posted on
By the Regenerative Evidence Guide Team A research-related injury is any harm caused by taking part in a study — and before you join one, federal rules require the consent form to tell you whether …
Continue Reading about Research Injury Costs: Questions Before Joining a Study →
posted on
By the Regenerative Evidence Guide Team Expanded access and clinical trial participation are two different FDA pathways to an unapproved product, and confusing them is an easy, costly mistake. A …
Continue Reading about Expanded Access vs. Clinical Trials: FDA Pathways Explained →
posted on
By the Regenerative Evidence Guide Team Clinical trial status labels describe where a study sits in its enrollment timeline, not whether the treatment works. "Recruiting" means the study is currently …
Continue Reading about Clinical Trial Status Labels Explained: Recruiting, Active, and Completed →
posted on
By the Regenerative Evidence Guide Team What Does "FDA Registered" Mean? "FDA registered" means a facility has told the FDA where it operates and what it makes there. It does not mean the FDA …
Continue Reading about What “FDA Registered” Can Mean for a Regenerative-Medicine Claim →